Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Conduit Pharmaceuticals (CDT)

Conduit Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDT
DateTimeSourceHeadlineSymbolCompany
12/12/202412:30GlobeNewswire Inc.Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and CyberneticsNASDAQ:CDTConduit Pharmaceuticals Inc
21/11/202412:30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
19/11/202421:30GlobeNewswire Inc.Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of DirectorsNASDAQ:CDTConduit Pharmaceuticals Inc
01/11/202420:45GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Restructuring and Additional NotesNASDAQ:CDTConduit Pharmaceuticals Inc
28/08/202412:00GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
12/08/202411:00GlobeNewswire Inc.Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
08/08/202410:30GlobeNewswire Inc.Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class TreatmentsNASDAQ:CDTConduit Pharmaceuticals Inc
16/07/202411:30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune DiseasesNASDAQ:CDTConduit Pharmaceuticals Inc
13/06/202412:00GlobeNewswire Inc.Conduit Pharmaceuticals to Join Russell 3000® IndexNASDAQ:CDTConduit Pharmaceuticals Inc
29/05/202420:21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTConduit Pharmaceuticals Inc
19/03/202411:00GlobeNewswire Inc.Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerNASDAQ:CDTConduit Pharmaceuticals Inc
11/03/202411:00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubNASDAQ:CDTConduit Pharmaceuticals Inc
31/01/202413:30GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
02/11/202312:30GlobeNewswire Inc.Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
11/10/202312:30GlobeNewswire Inc.Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656NASDAQ:CDTConduit Pharmaceuticals Inc
06/10/202312:30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTConduit Pharmaceuticals Inc
22/09/202313:01GlobeNewswire Inc.Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business CombinationNASDAQ:CDTConduit Pharmaceuticals Inc
10/11/200317:26PR Newswire (US)Mohawk/CDT Announces the Release of VersaLite(TM) Indoor/Outdoor Plenum Fiber Optic CableLSE:CDT
 Showing the most relevant articles for your search:NASDAQ:CDT